Austin Murata

Array ( [id] => 5112359 [patent_doc_number] => 20070196274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Immunoconjugates with improved efficacy for the treatment of diseases' [patent_app_type] => utility [patent_app_number] => 11/655263 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9787 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0196/20070196274.pdf [firstpage_image] =>[orig_patent_app_number] => 11655263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004511 [patent_doc_number] => 20070202079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases' [patent_app_type] => utility [patent_app_number] => 11/652008 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 37639 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202079.pdf [firstpage_image] =>[orig_patent_app_number] => 11652008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8701704 [patent_doc_number] => 08394926 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-12 [patent_title] => 'Pharmaceutical compositions with resistance to soluble CEA' [patent_app_type] => utility [patent_app_number] => 12/158611 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 31320 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12158611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4494220 [patent_doc_number] => 07956162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-07 [patent_title] => 'Cancer-associated antigen' [patent_app_type] => utility [patent_app_number] => 12/097336 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 25114 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/956/07956162.pdf [firstpage_image] =>[orig_patent_app_number] => 12097336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101236 [patent_doc_number] => 20070184498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Protein RS15A as a marker for colorectal cancer' [patent_app_type] => utility [patent_app_number] => 11/640520 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11630 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184498.pdf [firstpage_image] =>[orig_patent_app_number] => 11640520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5210044 [patent_doc_number] => 20070248628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Immunogens in cancer stem cells' [patent_app_type] => utility [patent_app_number] => 11/633858 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23430 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20070248628.pdf [firstpage_image] =>[orig_patent_app_number] => 11633858 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6348660 [patent_doc_number] => 20100021473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Bispecific Ligands With Binding Specificity to Cell Surface Targets and Methods of Use Therefor' [patent_app_type] => utility [patent_app_number] => 12/086115 [patent_app_country] => US [patent_app_date] => 2006-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 48762 [patent_no_of_claims] => 106 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12086115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435682 [patent_doc_number] => 08283450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Human monoclonal antibody human CD134 (OX40) and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/087436 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 10 [patent_no_of_words] => 34620 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12087436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070160 [patent_doc_number] => 20070191262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Cancer Therapy and Prevention Based on Modulation of Complement activity' [patent_app_type] => utility [patent_app_number] => 11/560155 [patent_app_country] => US [patent_app_date] => 2006-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29536 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191262.pdf [firstpage_image] =>[orig_patent_app_number] => 11560155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079190 [patent_doc_number] => 20070122414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Surface marker-directed cancer therapeutics' [patent_app_type] => utility [patent_app_number] => 11/595299 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 30036 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122414.pdf [firstpage_image] =>[orig_patent_app_number] => 11595299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968403 [patent_doc_number] => 08507213 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-08-13 [patent_title] => 'Methods and compositions for treating diseases targeting maba' [patent_app_type] => utility [patent_app_number] => 11/594160 [patent_app_country] => US [patent_app_date] => 2006-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36633 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11594160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11790090 [patent_doc_number] => 09399662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-26 [patent_title] => 'Concurrent chemotherapy and immunotherapy' [patent_app_type] => utility [patent_app_number] => 12/092180 [patent_app_country] => US [patent_app_date] => 2006-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6547 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12092180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5095092 [patent_doc_number] => 20070116701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-24 [patent_title] => 'Compositions and methods for diagnosing and treating cancer' [patent_app_type] => utility [patent_app_number] => 11/589993 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25870 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20070116701.pdf [firstpage_image] =>[orig_patent_app_number] => 11589993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5182986 [patent_doc_number] => 20070054333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'Tumor suppressor designated TS10Q23.3' [patent_app_type] => utility [patent_app_number] => 11/590556 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 56356 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20070054333.pdf [firstpage_image] =>[orig_patent_app_number] => 11590556 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258723 [patent_doc_number] => 20070212355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses' [patent_app_type] => utility [patent_app_number] => 11/552408 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11101 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212355.pdf [firstpage_image] =>[orig_patent_app_number] => 11552408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 247187 [patent_doc_number] => 07585939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-08 [patent_title] => 'Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes' [patent_app_type] => utility [patent_app_number] => 11/585544 [patent_app_country] => US [patent_app_date] => 2006-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12268 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/585/07585939.pdf [firstpage_image] =>[orig_patent_app_number] => 11585544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569303 [patent_doc_number] => 20090252681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Nanobodies and Polypeptides Against EGFR and IGF-IR' [patent_app_type] => utility [patent_app_number] => 12/083406 [patent_app_country] => US [patent_app_date] => 2006-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 76717 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252681.pdf [firstpage_image] =>[orig_patent_app_number] => 12083406 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574985 [patent_doc_number] => 20090142346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'Preventive/Remedy for Cancer' [patent_app_type] => utility [patent_app_number] => 11/992966 [patent_app_country] => US [patent_app_date] => 2006-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 61762 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142346.pdf [firstpage_image] =>[orig_patent_app_number] => 11992966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 803196 [patent_doc_number] => 07422899 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Antibodies to the human prolactin receptor' [patent_app_type] => utility [patent_app_number] => 11/538635 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 5 [patent_no_of_words] => 24802 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/422/07422899.pdf [firstpage_image] =>[orig_patent_app_number] => 11538635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4549 [patent_doc_number] => 07811984 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'BV8 nucleic acids and polypeptides with mitogenic activity' [patent_app_type] => utility [patent_app_number] => 11/536880 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 33615 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/811/07811984.pdf [firstpage_image] =>[orig_patent_app_number] => 11536880 [rel_patent_id] =>[rel_patent_doc_number] =>)